NAM
EW icon

Nexpoint Asset Management’s Edwards Lifesciences EW Stock Holding History

Nexpoint Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,000
Closed -$259K – 186
2021
Q4 		$259K Buy
+2,000
New +$233K 0.04% 178
2021
Q2 		– Sell
-10,050
Closed -$841K – 178
2021
Q1 		$841K Hold
10,050
– – 0.22% 66
2020
Q4 		$917K Sell
10,050
-15,000
-60% -$1.24M 0.3% 75
2020
Q3 		$2M Buy
25,050
+15,000
+149% +$1.17M 0.45% 41
2020
Q2 		$695K Hold
10,050
– – 0.16% 94
2020
Q1 		$632K Buy
+10,050
New +$725K 0.12% 112

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nexpoint Asset Management's EW Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 2,000 shares — an estimated $259K sold.

Nexpoint Asset Management first reported a position in EW in Q1 2020 and held it in 6 quarters. The position peaked at $2M in Q3 2020. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Nexpoint Asset Management reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 2,000 Edwards Lifesciences shares in Q1 2022, an estimated $259K.
  • Nexpoint Asset Management first reported a position in Edwards Lifesciences in Q1 2020 and held it in 6 quarters.
  • Nexpoint Asset Management's Edwards Lifesciences position peaked at $2M in Q3 2020.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.